Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2015 Nov 1.

Published in final edited form as: Psychopharmacology (Berl). 2014 May 7;231(22):4393–4402. doi: 10.1007/s00213-014-3591-5

Table 2.

Amplitude (uV) and latency (ms) 1 of the P50, N100, and P200 components in response to S1 and S2

	Placebo		0.04%		0.065%

	S1	S2	S1	S2	S1	S2
P50 Amp	2.58 (0.3)^*	1.50 (0.2)	2.29 (0.3)	1.48 (0.2)	1.62 (0.2)^*	1.44 (0.2)
P50 Lat	63.29 (2.7)	63.87 (2.4)	60.26 (1.6)	62.31 (2.5)	61.27 (1.7)	65.97 (1.9)
N100 Amp	8.39 (0.8)	4.39 (0.5)	6.61 (0.7)	4.72 (0.5)	6.63 (0.8)	4.50 (0.6)
N100 Lat	99.66 (4.4)	88.65 (2.8)	94.22 (2.5)	98.20 (4.0)	94.56 (3.3)	94.25 (3.1)
P200 Amp	18.01 (1.5)^*	6.19 (0.6)	14.93 (1.2)	5.98 (0.6)	12.03 (1.5)^*	5.27 (0.9)
P200 La	203.0 (6.0)	184.8 (7.3)	193.9 (7.2)	182.2 (6.8)	202.8 (6.5)	191.84 (9.3)

^*

Significant differences between dose groups (p<.05)